The UK Government's Rare Disease Action Plan 2024 has been published, detailing what the NIHR, DHSC and others have done over the past year to better meet the needs of patients with rare diseases.
In a major move to improve the accuracy and accessibility of breast cancer screening in India, Indira IVF has partnered with BD SurePath.
Johnson and Johnson announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved Rybrevant (amivantamab-vmjw) in combination with chemotherapy (carboplatin-pemetrexed) for the first-line treatment of patients w
The current impediments to bilateral relations include tariff and non-tariff barriers, complex custom clearance procedures, IPR and data localization issues†- David Sanford Wolfe, Chairman, Aaron Capital, Inc USA.
The Indian active pharmaceutical ingredient (API) industry believes that the Make in India initiative and the PLI (production-linked incentive) scheme will help limit imports from China.
To revolutionize the healthcare landscape, the 8th Edition of CAHOCON 2024 is set to unfold between April 6 and 7 at the Biswa Bangla Convention Centre in Kolkata with a theme that resonates globally.
India has continued on toward turned into a significant exporter of bulk drugs and medical devices, Health Minister, Mansukh Mandaviya said. As per him, India dealt with plans and plans to de-risk its store network from worldwide ideas and...
Ginkgo Bioworks, a startup developing the leading platform for cell programming and biosecurity, has announced the purchase of key assets from Reverie Labs, which created and applied AI/ML techniques to expedite drug discovery. Ginkgo has...
Intelligent Bio Solutions Inc., a medical technology company delivering smart, rapid, non-invasive testing solutions, has announced its partnership with Cliantha Research, a full-service clinical research organization, to perform a pharmacokinetic
Stryker, a major player in the medical technology space, expanded its prototyping and testing facilities in India on Thursday. According to a press release, this move represents significant growth in our RandD landscape.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")